GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (STU:ZR8) » Definitions » EPS (Diluted)

Oncodesign Precision Medicine (STU:ZR8) EPS (Diluted) : € (TTM As of Jun. 2022)


View and export this data going back to 2022. Start your Free Trial

What is Oncodesign Precision Medicine EPS (Diluted)?

Oncodesign Precision Medicine's Earnings per Share (Diluted) for the six months ended in Jun. 2022 was €-0.48.

Oncodesign Precision Medicine's EPS (Basic) for the six months ended in Jun. 2022 was €-0.48.

Oncodesign Precision Medicine's EPS without NRI for the six months ended in Jun. 2022 was €-0.48.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Oncodesign Precision Medicine EPS (Diluted) Historical Data

The historical data trend for Oncodesign Precision Medicine's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine EPS (Diluted) Chart

Oncodesign Precision Medicine Annual Data
Trend Dec20 Dec21
EPS (Diluted)
-0.02 -0.43

Oncodesign Precision Medicine Semi-Annual Data
Dec20 Dec21 Jun22
EPS (Diluted) - - -0.48

Competitive Comparison of Oncodesign Precision Medicine's EPS (Diluted)

For the Biotechnology subindustry, Oncodesign Precision Medicine's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncodesign Precision Medicine's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncodesign Precision Medicine's PE Ratio distribution charts can be found below:

* The bar in red indicates where Oncodesign Precision Medicine's PE Ratio falls into.


Oncodesign Precision Medicine EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Oncodesign Precision Medicine's Diluted EPS for the fiscal year that ended in Dec. 2021 is calculated as

Diluted EPS (A: Dec. 2021 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-2.944-0)/6.851
=-0.43

Oncodesign Precision Medicine's Diluted EPS for the quarter that ended in Jun. 2022 is calculated as

Diluted EPS (Q: Jun. 2022 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-3.256-0)/6.851
=-0.48

Oncodesign Precision Medicine  (STU:ZR8) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Oncodesign Precision Medicine EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncodesign Precision Medicine (STU:ZR8) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (STU:ZR8) » Definitions » EPS (Diluted)
Comparable Companies
Traded in Other Exchanges
N/A
Address
18 rue Jean Mazen, Dijon, FRA, 21000
Website
https://www.opm.oncodesign.com
Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine (STU:ZR8) Headlines

No Headlines